NCT01565291View on ClinicalTrials.gov

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Alzheimer Disease
Interventions
DRUG

florbetapir F 18

IV injection, 370MBq (10mCi), single dose

Trial Locations (3)

21287

Research Site, Baltimore

21901

Research Site, North East

07740

Research Site, Long Branch

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY